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Background
• Osteoporosis, a skeletal disease, is a serious public health problem with an 
estimated 1.4 million Canadians and 10 million Americans affected.
• The epidemiological and clinical importance lies in the resulting fractures.
• The routine management of osteoporosis should target all aspects of the 
disease, including maximizing and preserving bone mass and preventing 
future fractures through pharmacotherapy and lifestyle modification. 
• Despite strong evidence-based rationale for both the primary and secondary 
prevention of osteoporosis, there remains an overall low prevalence of 
osteoporosis treatment in older adults. 
Cohort Selection 
Factors Predicting No Drug 
Treatment Post-Fracture
Results 
Osteoporosis treatment:
• Low treatment rate prior to incident fracture (15% 
of the sample).
• Treatment rate improved to 19% following the 
index fracture.
• Those who received treatment following the 
fracture were significantly younger, more often 
female, and had fewer co-morbid conditions (p < 
Materials & Methods
• To determine if older adults with 
multiple co-morbid conditions 
were less likely to receive 
osteoporosis treatment following 
an incident osteoporosis 
fracture than younger healthier 
patients with fewer co-morbid 
conditions.
Objectives
Design: 
• Retrospective nested cohort study.
Data Sources
• There is some question whether low treatment rates in older adults are simply 
age related variations (in treatments) or due to the presence of co-morbid 
conditions. 
Variable
Adjusted odds ratio 
(95% Confidence 
Interval)
p-value
Constant 0.220 .000
Age category (years) .000
65–69 1 (reference)
70–74 1.12 (0.86 – 1.47) 0.389
75–79 0.96 (0.75 – 1.24) 0.777
80–84 0.90 (0.70 - 1.16) 0.414
85–89 0.64 (0.49 - 0.83) 0.001
≥ 90 0.47 (0.35 - 0.63) 0.000
Sex 0.000
Female 1 (reference)
Male 0.23 (0.19–0.29) 0.000
Charlson-Deyo Index (CDI) 0.000
≤ 1 1 (reference)
2–3 0.83 (0.73–0.94) 0.003
≥ 4 0.63 (0.48–0.83) 0.001
Fracture site 0.000
Hip 1 (reference)
Arm / Wrist 1.10 (0.93 – 1.32) 0.273
Pelvis 1.27 (1.01 – 1.60) 0.039
Vertebrae 2.64 (2.12 – 3.29) 0.000
Ribs 1.01 (0.69 – 1.46) 0.976
Health Authority 0.000
Results: Patient Characteristics *
0.001).
• The treatment rate improved significantly every 
year (p < 0.001).
• Patients residing in more central health regions 
received treatment significantly more often than 
those residing in the Northern region (p < 0.001).
• Age, sex, co-morbidity (CDI), fracture site, and 
health region were all significantly associated with 
the dispensation of an osteoporosis medication 
within six months following the index fracture.
Those with ≥ 4 co-
morbidities were 1.6 times 
less likely to have been 
dispensed treatment
Subjects ≥ 90
years were dispensed 
medication less than 50% of 
the time compared to subjects 
69 years and younger 
7% 4%
Fracture category
Hip
Variable Total fracture cohort
n = 12,025
Year of fracture
1999/2000 4,037 (33.6)
• De-identified administrative healthcare data derived from the British 
Columbia (Canada) Linked Health Database (BCLHD).
• Data bases used: Prescription data (PharmaCare) and hospital separations 
(Discharge Abstract Database [DAD]). 
Study Population
• All residents in the province of BC, Canada aged 65 years and older who 
had continuous enrolment in the PharmaCare prescription benefits plan 
between 1999 and 2002.
Outcome Measures
• Dependent variable - osteoporosis medication dispensation. 
• Independent variables (main)- age and co-morbidity (CDI). 
• Covariates - sex, fracture site, year of fracture, health region, and 
osteoporosis treatment prior to the index fracture. 
Statistical Analysis
• Using multivariate logistic regression techniques, we used the Enter 
procedure in which all independent variables are entered in a single step and 
then tested for the possibility of statistical interaction between the main 
independent variables (age and CDI score) and all other covariates.  
• We pre- specified that we would consider only interaction terms that 
achieved a level of statistical significance of p < 0.10. 
• The calculated ORs were considered statistically significant if the 95% CI did 
not include 1.
Despite the wide availability of osteoporosis 
medications, our findings suggest that the 
majority of older adults, many of who have at 
least one co-morbid condition, are not 
receiving treatment to prevent the 
progression of the disease and to prevent 
further fractures. 
Conclusions
Vancouver Coastal 1 (reference)
Interior 0.68 (0.58 – 0.80) 0.000
Fraser 0.92 (0.80- 1.07) 0.287
Vancouver Island 0.69 (0.59 – 0.81) 0.000
Northern 0.48 (0.35 – 0.67) 0.000
Missing 0.71 ( 0.39 – 1.32) 0.282
Prior treatment .000
No treatment 1 (reference)
Prior treatment 15.89 (9.69 – 26.04) 0.000
Prior treatment was 
the strongest 
predictor of 
osteoporosis 
treatment following 
an incident fracture
Those with a 
fractured vertebrae 
were 2.64 times 
more likely to 
receive treatment
63%17%
9%
Arm / 
wrist
Pelvis
Vertebra
Ribs
2000/2001 3,770 (31.4)
2001/2002 4,218 (35.1)
Charlson-Deyo Index (CDI) †
≤ 1 7,599 (63.2)
2–3 3,724 (31)
≥ 4 702 (5.8)
Health Authority †
Vancouver 
Coastal 3,202 (26.6)
Interior 2,611 (21.7)
Fraser 3,047 (25.3)
Vancouver 
Island 2,531  (21.0)
Northern 525 (4.4)
Unknown 109 (0.9) 65–69 70–74 75–79 80–84 85–89 ≥ 90
Male 383 509 629 592 561 343
Female 657 1051 1720 2122 2082 1302
0
500
1000
1500
2000
2500
3000
C
o
u
n
t
Age and Sex †
* All data are shown as number (percentage)
† p < 0.001 for chi square differences between categories within group
